Recent Posts
- Exploring Tau Protein’s Role in Glaucoma: New Insights and Therapeutic Potential
- FDA-mandated CAR-T monitoring period could be halved, say researchers
- Ancestral CRISPR-Cas13 Ribonucleases Discovered: Implications for Genome Editing
- KBI Biopharma Expands Manufacturing Contract with Global Pharmaceutical Company
- Emmes Group partners with Miimansa AI to accelerate adoption of Generative AI in clinical research
AAV One-stop Solution
Tags
AAV2
AAV5
AAV based gene therapy
AAV Capsid
ALS
Alzheimer’s Disease
brain vasculature
cancer
CAR-T
Cell Therapy
COVID-19
COVID vaccine
CRISPR
CRISPR/Cas
Drug Development
dystrophin
eye disease
FDA
gene editing
gene therapy
genetic engineering
genome editing
GMP plasmid
hearing
heart disease
hemophilia
Hemophilia B
hepatitis research
HIV
immunotherapy
liver cancer
mRNA
Neurodegenerative Diseases
Orphan Drug
Parkinson
rare disease
Retinoschisis
RNA
RNAi therapeutics
RNA vaccines
SARS-CoV-2
Sickle Cell Disease
SMA Treatment
thyroid
zolgensma